Brind.

Accelerated customer purchases in China benefited sales for a company, while Quattro saw increased sell-through in the U.S., coinciding with a comment from William Blair on Elanco's earnings.

1 report, 1 independent Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Accelerated customer purchases in China benefited sales for a company, while Quattro saw increased sell-through in the U.S., coinciding with a comment from William Blair on Elanco's earnings.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • BenzingaElanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted ea